stage 4 cancer
Stage IV cancer patients who suffer from anxiety may want to investigate a new research study recently approved by the Food and Drug Administration (FDA) taking place at specific aim of the study is to learn whether the psychoactive drug, psilocybin, might be effective in reducing anxiety, depression and physical pain, and therefore improving quality of life for Stage IV cancer patients.

Psilocybin is a novel agent that produces a profound alteration in your state of consciousness. To speak to a patient who went through this clinical trial, contact David Feuerherd at 310-225-0234. For more information on the trial, call Charles S. Grob, MD, at 310-222-3175.

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center () is one of the largest independent, not-for-profit biomedical research institutes in Los Angeles County. Affiliated with both the David Geffen School of Medicine at UCLA and the Harbor-UCLA Medical Center, the Institute has an annual budget of over $67 million and currently supports more than 1,000 research studies in areas such as cardiology, emerging infections, cancer, women's health, reproductive health, vaccine research, respiratory physiology, neonatology, molecular biology, and genetics.